These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1521142)

  • 1. Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neurons in the paraventricular nucleus.
    de Goeij DC; Jezova D; Tilders FJ
    Brain Res; 1992 Apr; 577(1):165-8. PubMed ID: 1521142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurones of the hypothalamus in lactating rats: evidence from immunotargeted lesions and immunohistochemistry.
    Walker CD; Tilders FJ; Burlet A
    J Neuroendocrinol; 2001 Jan; 13(1):74-85. PubMed ID: 11123517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosterone differentially modulates expression of corticotropin releasing factor and arginine vasopressin mRNA in the hypothalamic paraventricular nucleus following either acute or repeated restraint stress.
    Pinnock SB; Herbert J
    Eur J Neurosci; 2001 Feb; 13(3):576-84. PubMed ID: 11168566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single stress induces long-lasting elevations in vasopressin mRNA levels in CRF hypophysiotrophic neurones, but repeated stress is required to modify AVP immunoreactivity.
    Aubry JM; Bartanusz V; Jezova D; Belin D; Kiss JZ
    J Neuroendocrinol; 1999 May; 11(5):377-84. PubMed ID: 10320565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats.
    de Goeij DC; Kvetnansky R; Whitnall MH; Jezova D; Berkenbosch F; Tilders FJ
    Neuroendocrinology; 1991 Feb; 53(2):150-9. PubMed ID: 1849619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus.
    Paulmyer-Lacroix O; Anglade G; Grino M
    J Mol Endocrinol; 1994 Dec; 13(3):313-20. PubMed ID: 7893349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA.
    Ma XM; Levy A; Lightman SL
    Endocrinology; 1997 Oct; 138(10):4351-7. PubMed ID: 9322950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.
    Kageyama K; Kumata Y; Akimoto K; Takayasu S; Tamasawa N; Suda T
    Stress; 2011 Sep; 14(5):520-9. PubMed ID: 21438782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of corticotropin-releasing factor-containing neurons in the paraventricular nucleus of the hypothalamus by interleukin-1 in the rat.
    Ju G; Zhang X; Jin BQ; Huang CS
    Neurosci Lett; 1991 Nov; 132(2):151-4. PubMed ID: 1784415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress.
    Franco-Bourland RE
    Neurochem Res; 1998 May; 23(5):695-701. PubMed ID: 9566608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-existence of CRF and vasopressin immunoreactivity in parvocellular paraventricular neurons of rat hypothalamus.
    Piekut DT; Joseph SA
    Peptides; 1986; 7(5):891-8. PubMed ID: 3540910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin-containing neurons of the hypothalamic parvocellular paraventricular nucleus of the jerboa: plasticity related to immobilization stress.
    Barakat Y; Pape JR; Boutahricht M; El Ouezzani S; Alaoui A; Chaigniau M; Barakat L; Tramu G; Mâgoul R
    Neuroendocrinology; 2006; 84(6):396-404. PubMed ID: 17384516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evidence against the coexistence of a corticotropin-releasing factor and oxytocin or vasopressin in the rat paraventricular nucleus.
    Taniguchi Y
    Arch Histol Jpn; 1984 Nov; 47(5):475-83. PubMed ID: 6335830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons.
    Sakamoto F; Yamada S; Ueta Y
    Regul Pept; 2004 May; 118(3):183-91. PubMed ID: 15003835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy.
    Kovács K; Kiss JZ; Makara GB
    Neuroendocrinology; 1986; 44(2):229-34. PubMed ID: 3540700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis.
    Liposits Z; Paull WK; Sétáló G; Vigh S
    Histochemistry; 1985; 83(1):5-16. PubMed ID: 3900007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of the human hypothalamus.
    Mouri T; Itoi K; Takahashi K; Suda T; Murakami O; Yoshinaga K; Andoh N; Ohtani H; Masuda T; Sasano N
    Neuroendocrinology; 1993 Jan; 57(1):34-9. PubMed ID: 8479614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.